Does Red Light Therapy Help Dementia and Alzheimer's?

Close-up of a transcranial red light therapy helmet glowing with warm red and near-infrared LEDs, placed on a treatment table in a modern clinical setting

Does Red Light Therapy Help Dementia and Alzheimer’s?

Possibly, and the early results are encouraging. In small randomized trials, near-infrared light shone on the head raised scores on memory and thinking tests, by about 3 points on a 30-point test in people with Alzheimer’s. No trial has shown that it slows the disease or works over the long term, so it is a promising add-on, not a treatment to rely on.

Red light therapy goes by several names: photobiomodulation (PBM), low-level laser therapy, or near-infrared therapy. All mean the same idea. A laser or LED panel sends red or near-infrared light into the body. When it is aimed through the scalp and skull, it is called transcranial PBM.

Near-infrared is just past red on the light spectrum, so it is invisible to the eye.

What the Data Show

A 2021 systematic review found 36 studies of PBM relevant to dementia: 9 in cells, 17 in animals and 10 in people with dementia. All 36 reported positive results. The authors warned that the patient studies were small, some had no placebo group, and few used brain scans to measure change.

Since then, the evidence has grown. A 2026 network meta-analysis of randomized trials in Alzheimer’s disease compared PBM with two other brain stimulation methods, tDCS (a weak electrical current) and rTMS (magnetic pulses). All three improved thinking scores compared with control, and PBM had the largest estimated effect. It improved scores on the Mini-Mental State Examination (MMSE), a 30-point memory and thinking test, by about 3.1 points.

A 2022 meta-analysis of 13 studies with 608 people with dementia found light treatment was linked to better overall thinking, especially attention, planning and working memory. The gains were clear in the short term. Benefit at later follow-up was not statistically significant, so the authors concluded that evidence for long-term benefit was lacking.

The largest single trial I found was in people with mild cognitive impairment (MCI), the stage of memory loss before dementia. In this randomized, placebo-controlled trial of 80 people with MCI due to Alzheimer’s, participants used an 808 nm near-infrared device on the forehead at home, six times a week for 12 weeks. On the Montreal Cognitive Assessment (MoCA), another 30-point test, scores rose by 3.87 points with the real device and fell by 0.74 points with the placebo device. Depression scores did not change.

In people who already had dementia, a double-blind trial of 32 patients found MMSE scores rose by about 2.5 points by week 8 with laser treatment, while the sham group did not improve. But the Clinical Dementia Rating, which measures how dementia affects daily life, did not change in the laser group.

That last point is the honest summary. Test scores move. Whether daily life gets better is not yet shown.

Is Red or Infrared Light Better for the Brain?

Near-infrared. In a study of 8 human cadaver heads, 808 nm near-infrared light passed through the scalp, skull and brain coverings and reached about 40 mm (1.6 inches) into the brain. Inside brain tissue, 808 nm light was absorbed and scattered less than 660 nm red light.

The trial results point the same way. In the 2022 meta-analysis, near-infrared LEDs and lasers were more strongly linked to better thinking than ordinary visible light. A 2023 review of human studies found one of the most common clinical setups was 810 nm near-infrared at 20 to 25 mW/cm², and all 9 of its studies in people with memory complaints, MCI or dementia reported positive outcomes.

A red light panel built for skin is not the same as the devices tested on the brain.

How Does Red Light Therapy Work on the Brain?

The leading idea is that light energy is absorbed by mitochondria, the parts of each cell that make energy. Brain cells in Alzheimer’s struggle to make enough of it.

There are early signs in people. In a 20-person randomized pilot in MCI, the active device changed blood markers of energy use, increased connections within a key memory network on brain scans, and lowered IL-6, a marker of inflammation. In an 8-person pilot in dementia, home treatment increased blood flow in the brain on MRI. Both studies are tiny, so these are clues, not proof.

How to Use Red Light Therapy for Dementia

No standard schedule exists yet, and no trial has compared one schedule against another. The trials that showed benefit share a pattern, though.

StudyWhoLightSchedule
Chun 202680 with MCI808 nm, forehead6 times a week, 12 weeks, at home
Rashidi-Ranjbar 202620 with MCIPulsed 810 nm, 20 min6 days a week, 6 weeks, at home
Guo 20259 with Alzheimer’s810 nm whole-head, 30 min6 times a week, 4 months
Blivet 202253 with Alzheimer’sBrain and gut, 25 min40 sessions over 8 weeks
Chao 20198 with dementiaHead and nose (Vielight Neuro Gamma)3 times a week, 12 weeks, at home

In the trials in this table, sessions ran 20 to 30 minutes, three to six times a week, for 6 weeks to 4 months, and the wavelength was usually 808 to 810 nm. Because long-term benefit is unproven, gains may fade if treatment stops.

What Is the Best Red Light Helmet for Dementia?

No study has compared brands, so there is no proven best device. What the research supports is a device that delivers near-infrared light, not only visible red.

Two device types appear in the trials. The first is a headset with LED pads plus a nose clip, such as the Vielight Neuro Gamma used in the 8-person dementia pilot. The second is a whole-head helmet: in an open-label study of 9 Alzheimer’s patients, an 810 nm helmet used for 4 months raised MMSE scores by an average of 3.2 points, and the gains lasted at least 2 months after stopping. That study had no comparison group.

Keep the funding in mind. The 20-person pilot used devices provided by Vielight, whose chief executive is a co-author, and the helmet study’s lead author holds shares in a medical equipment company.

Is Red Light Therapy Safe for Older Adults With Dementia?

In the trials so far, yes. In a sham-controlled trial of 53 Alzheimer’s patients, side effects were mainly mild and were as common in the sham group as with real treatment, with no serious adverse events. More than 9 in 10 patients stuck with the 40 sessions.

In the 20-person MCI pilot, 4 people on the real device and 6 on the sham reported side effects, and none were serious. The 80-person trial reported no device-related side effects.

These trials lasted weeks to months. Safety over years has not been studied. The light should never be aimed into the eyes, and anyone with a light-sensitive condition or a history of seizures should ask a doctor first.

Is Red Light Therapy the Same as Light Therapy for Dementia?

No. “Light therapy” for dementia usually means a bright light box. That light enters the eyes and resets the body clock. A 2024 meta-analysis of 24 randomized trials with 1,074 people with dementia found bright light therapy gave small to medium improvements in sleep, depression, agitation and thinking.

Red or near-infrared therapy aims light at the head to reach brain cells directly. The two can be used together, but they are different tools.

Dr. Kumar’s Take

Current Alzheimer’s drugs offer modest benefit, so a safe, painless home treatment that moves memory scores by a few points deserves attention. The direction of the evidence has been consistent: every review finds positive results, and the trials keep getting larger and better controlled.

But I want to be clear about what has not been shown. No trial has followed people long enough to show that light slows the disease, keeps someone living at home longer, or improves daily function. The trials are small and several have ties to device makers. If you try it, use near-infrared, follow a schedule like the ones in the trials, keep every other treatment in place, and judge it by what you see over months.

Practical Takeaways

  • Choose near-infrared (around 810 nm). Visible red alone is not what the brain trials tested.
  • Follow a trial-like schedule: 20 to 30 minutes, three to six times a week, for at least 6 weeks.
  • Keep all other treatment in place. This is an add-on, not a replacement.
  • Track something concrete, such as a memory test score or daily tasks, to see if it helps.
  • Do not shine it in the eyes, and check with a doctor first if seizures or light sensitivity are a concern.
  • Add morning bright light for sleep and mood, which is a separate tool with its own trial evidence.

FAQs

Can red light therapy reverse dementia?

No. Trials show modest gains on memory and thinking tests, about 3 points on a 30-point scale. No study has shown that it reverses or stops the disease.

How long does red light therapy take to work for dementia?

The trials measured changes after 6 weeks to 4 months of regular sessions, and one dementia trial saw higher scores by week 2. Benefits beyond the treatment period are not proven.

Does red light therapy help memory loss before dementia?

It may. In the largest placebo-controlled trial, people with mild cognitive impairment improved by almost 4 points on a 30-point thinking test after 12 weeks, while the placebo group slipped slightly.

Can you use red light therapy for dementia at home?

Yes. Most recent trials used home devices, run by the patient or a family member, and people stuck with them well. Pick a near-infrared device and follow a set schedule.

Does red light therapy have side effects?

In trials, side effects were mild and as common with sham devices as with real ones. No serious side effects were reported, though no study has lasted more than a few months.

Bottom Line

Near-infrared light on the head is one of the more promising non-drug ideas for dementia and Alzheimer’s. Small randomized trials show memory and thinking scores rising by a few points, with mild side effects. It has not been shown to slow the disease or improve daily life over the long term. Used at near-infrared wavelengths on a regular schedule, it is a reasonable add-on to try, not a replacement for care.

References

  1. Salehpour F, et al. Photobiomodulation therapy for dementia: a systematic review of pre-clinical and clinical studies. J Alzheimers Dis, 2021 pubmed.ncbi.nlm.nih.gov
  2. Xu W, et al. Photobiomodulation, tDCS and rTMS in Alzheimer's disease: a network meta-analysis of randomized trials. Lasers Med Sci, 2026 pubmed.ncbi.nlm.nih.gov
  3. Zhu G, et al. Phototherapy for cognitive function in patients with dementia: a systematic review and meta-analysis. Front Aging Neurosci, 2022 pubmed.ncbi.nlm.nih.gov
  4. Lee TL, et al. Can transcranial photobiomodulation improve cognitive function? A systematic review of human studies. Ageing Res Rev, 2023 pubmed.ncbi.nlm.nih.gov
  5. Chun H, et al. Home-based transcranial photobiomodulation in mild cognitive impairment due to Alzheimer's disease: a randomized trial. J Alzheimers Dis, 2026 pubmed.ncbi.nlm.nih.gov
  6. Kheradmand A, et al. Low-level laser therapy on cognitive symptoms of patients with dementia: a randomized clinical trial. Photobiomodul Photomed Laser Surg, 2022 pubmed.ncbi.nlm.nih.gov
  7. Blivet G, et al. A randomized, sham-controlled trial of brain-gut photobiomodulation therapy: safety and patient compliance. J Alzheimers Dis, 2022 pubmed.ncbi.nlm.nih.gov
  8. Rashidi-Ranjbar N, et al. Transcranial photobiomodulation in mild cognitive impairment: a pilot randomized controlled trial. J Alzheimers Dis, 2026 pubmed.ncbi.nlm.nih.gov
  9. Chao LL. Effects of home photobiomodulation treatments in patients with dementia: a pilot trial. Photobiomodul Photomed Laser Surg, 2019 pubmed.ncbi.nlm.nih.gov
  10. Guo R, et al. Whole-head 810 nm near-infrared therapy in Alzheimer's disease: a pilot study. J Alzheimers Dis, 2025 pubmed.ncbi.nlm.nih.gov
  11. Tedford CE, et al. Transcranial and intraparenchymal light penetration in human cadaver brain tissue. Lasers Surg Med, 2015 pubmed.ncbi.nlm.nih.gov
  12. Aini N, et al. Light therapy on sleep, depression, neuropsychiatric behaviors and cognition in dementia: a meta-analysis of randomized trials. Am J Geriatr Psychiatry, 2024 pubmed.ncbi.nlm.nih.gov

Get Dr. Kumar's free health protocols

Evidence-based playbooks from Dr. Ravi Kumar, MD, a board-certified neurosurgeon, plus a weekly research review. Enter your email and I'll send you the relevant protocol.

By subscribing, you agree to receive emails from The Dr Kumar Discovery. You can unsubscribe at any time. Privacy Policy

The Dr Kumar Discovery Podcast
Podcast

The Dr Kumar Discovery

Where science meets common sense. Practical, unbiased answers to today's biggest health questions.

Browse all episodes →